Page 60 - Product Testing News Today

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank Affimed N.V.January 11, 2021 GMT €10 million available at closing and up to €15 million available upon achievement of certain milestones Heidelberg, Germany, January 11, 2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cance...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Beam Therapeutics Appoints Leading Healthcare Executive Kate Walsh to its Board of Directors Beam TherapeuticsJanuary 11, 2021 GMT CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Kate Walsh, president and chief executive officer of the Boston Medical Cent...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

If most of the population is vaccinated against COVID-19, then the coronavirus wouldn’t have enough new hosts and the pandemic would burn out. That transformational phenomenon is known as “herd

Press release content from Business Wire. The AP news staff was not involved in its creation. United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna January 8, 2021 GMT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 8, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved its mRNA ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. Can-Fite Announces Publication of Namodenoson Liver Cancer Study in Peer Reviewed Journal—Cancers January 8, 2021 GMT PETACH TIKVA, Israel--(BUSINESS WIRE)--Jan 8, 2021-- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced a scientific paper tit...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Correction: COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate ... Compass PathwaysJanuary 8, 2021 GMT COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicat...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy January 8, 2021 GMT FLORHAM PARK, N.J. and NEW YORK, Jan. 8, 2021 /PRNewswire/ -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived from t...

Press release content from Business Wire. The AP news staff was not involved in its creation. Biodesix Anticipates Strong Preliminary Fourth Quarter 2020 Revenue (unaudited) January 8, 2021 GMT BOULDER, Colo.--(BUSINESS WIRE)--Jan 8, 2021-- Biodesix, Inc. a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company expects to report record fourth quarter 2020 preliminary unaudited revenue in a range of $25 million to $27 million. The strength...